Randomized phase 2 study of subcutaneous amifostine versus epoetin-α given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer

Cancer ◽  
2008 ◽  
Vol 113 (7) ◽  
pp. 1623-1631 ◽  
Author(s):  
Hye-Suk Han ◽  
Ji-Youn Han ◽  
Sun Young Yu ◽  
Hong Ryull Pyo ◽  
Hyae Young Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Concurrent Chemotherapy ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Limited Disease ◽  
Hyperfractionated Radiotherapy ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

Cancer ◽  
2018 ◽  
Vol 124 (24) ◽  
pp. 4667-4675 ◽  
Author(s):  
Daniel Morgensztern ◽  
Manuel Cobo ◽  
Santiago Ponce Aix ◽  
Pieter E. Postmus ◽  
Conrad R. Lewanski ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Second Line ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document